Related Experiment Video
Updated: Mar 9, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children
Insights
Screening overweight children for impaired glucose tolerance (IGT) can be improved. Elevated blood pressure and liver enzymes are key indicators, increasing the predictability of IGT in pediatric populations.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Debate exists on optimal screening criteria for impaired glucose tolerance (IGT) in overweight and obese children.
- Oral glucose tolerance testing (OGTT) is used for diagnosis, but identifying high-risk individuals is crucial.
Purpose of the Study:
- To identify risk factors that predict the presence of IGT in overweight children.
- To evaluate the effectiveness of combining screening parameters for improved IGT detection.
Main Methods:
- A cohort of overweight children undergoing OGTT was analyzed.
- Association of anthropometric and laboratory parameters with IGT was determined.
- The sensitivity of screening for IGT using combined parameters was assessed.
Main Results:
- Out of 145 children, 11 had IGT, with two also having impaired fasting glucose (IFG).
- Elevated blood pressure (p=0.025) and elevated liver enzymes (p=0.003) were significantly associated with IGT.
- Screening based on elevated blood pressure or liver enzymes achieved a sensitivity of 1.00 for IGT detection.
Conclusions:
- Screening overweight children with elevated blood pressure or elevated liver enzymes significantly enhances IGT predictability.
- Combining these parameters improves IGT screening compared to using IFG alone.
- This approach offers a more sensitive method for identifying children at risk for IGT.
Background:
There is debate on which overweight and obese children should be screened for the presence of impaired glucose tolerance (IGT) by oral glucose tolerance testing (OGTT). The objective of the study was to identify risk factors predictive of the presence of IGT.
Methods:
In a cohort of overweight children, who underwent OGTT, we determined the association of anthropometric and laboratory parameters with IGT and whether combining parameters improved the sensitivity of screening for IGT.
Results:
Out of 145 patients, IGT was present in 11, of whom two had impaired fasting glucose (IFG). Elevated blood pressure (p=0.025) and elevated liver enzymes (p=0.003) were associated with IGT, whereas IFG was not (p=0.067), screening patients with either one of these parameters predicted IGT with a high sensitivity of 1.00, and a number needed to screen of 5.7.
Conclusions:
Screening all patients with either IFG, presence of elevated blood pressure and elevated liver enzymes, significantly increases predictability of IGT compared to using IFG alone.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity